|  | 


India registers 20,035 new cases of Covid-19; recoveries approach 9.9 million


India’s coronavirus disease case count (Covid-19) rose to 10,286,709 on the first day of the new year as the country recorded 20,035 new infections in the previous 24 hours, the Ministry of Health dashboard showed on Friday. Union Health. The country’s latest surge in Covid-19 cases continues the recent trend of low new infections daily, up from more than 90,000 each day in September.

Click here for full Covid-19 coverage

The number of active cases continues to fall and is currently at 254,254, 3,402 less than Thursday, the board showed. Recoveries, meanwhile, continue to rise and currently stand at 9,883,461, with 23,181 patients – more than new infections – recovered from the disease in the last 24 hours. However, in the same duration, the virus also claimed 256 more lives, bringing the death toll to 148,994. Recoveries, active cases, and deaths contribute 96.08%, 2.47%, and 1.45%, respectively, of the country’s total Covid-19 cases.

The latest figures from India come a day before a nationwide vaccination test is scheduled for Saturday. Earlier in the week, a two-day trial was conducted in four states – Andhra Pradesh, Assam, Gujarat and Punjab – on December 28 and 29. Also on Friday, the subject matter expert committee (SEC) of the Central Medicines Standards Control Organization (CDSCO) is scheduled to meet to review Emergency Use Authorization (EUA) applications submitted by the Serum Institute of India. (SII) based in Pune and Bharat Biotech International Limited based in Hyderabad.

Read also | Key expert panel meets today to review data on Covid-19 vaccines from Serum Institute and Bharat Biotech

While IBS will manufacture the University of Oxford-AstraZeneca candidate vaccine Covishield in India, Bharat Biotech has developed the country’s first indigenous vaccine candidate, Covaxin. However, it was the American Pfizer Inc, which was the first to file a US application in India, although since then it has not submitted for submission on earlier dates and has sought more time.

Reference site